Optimal strategies to screen health care workers for COVID-19 in the US: a cost-effectiveness analysisResearch Published on 2022-01-152022-10-31 Journal: Cost Effectiveness and Resource Allocation : C/E [Category] COVID-19, [키워드] Analysis Antigen applied approach Asymptomatic Care Characteristics clinical disease conducted cost-effectiveness COVID-19 defined determine HCW HCWs Health Health care Health care worker health care workers health-care identify IgG Immunity IMPROVE Infection infections Interaction outcome pandemic patients PCR PCR test PCR testing post-symptom onset Prevalence provide reduce Result Safe SARS-CoV-2 Screening sensitivity analysis supplementary material symptomatic Symptoms Transmission transmission of SARS-CoV-2 with COVID-19 yielding [DOI] 10.1186/s12962-021-00336-x PMC 바로가기 [Article Type] Research
Comparative effectiveness of mRNA-1273 and BNT162b2 against symptomatic SARS-CoV-2 infection증상이 있는 SARS-CoV-2 감염에 대한 mRNA-1273 및 BNT162b2의 비교 효과Article Published on 2022-01-142022-09-11 Journal: Med (New York, N.Y.) [Category] SARS, 변종, 진단, 치료제, [키워드] 95% CI 95% confidence interval acute respiratory syndrome acute respiratory syndrome coronavirus acute respiratory syndrome coronavirus 2 age BNT162b2 Breakthrough infection breakthrough infections Case-control Comorbidities Comparative comparative effectiveness coronavirus coronavirus disease Coronavirus disease 2019 COVID-19 demographic characteristics effective Effectiveness Ethnicity Geography Health highlight imperative Infection Mayo Clinic MONITOR mRNA mRNA vaccines mRNA-1273 Odds ratio PROTECT respiratory Safe SARS-CoV-2 Sex study duration symptomatic symptomatic infection symptomatic SARS-CoV-2 infection vaccination Vaccine Vaccines variant was reduced [DOI] 10.1016/j.medj.2021.12.002 PMC 바로가기 [Article Type] Article
Mitochondrial Dysfunction Associates With Acute T Lymphocytopenia and Impaired Functionality in COVID-19 PatientsImmunology Published on 2022-01-142022-11-01 Journal: Frontiers in Immunology [Category] COVID-19, [키워드] acute phase acute respiratory syndrome Associate association Asymptomatic CD4 CD4 T-cell CD8 T cell CD8 T-cell convalescent coronavirus COVID-19 demonstrated Disease progression effector memory exhibited flow cytometry Frequency functional Hospital admission Hyperactivation Impaired impairment Infection Lower lymphocytopenia mechanism memory memory T cell Mild mitochondrial dysfunction mitochondrial dysfunction (MD) peptide phenotype proportion reduction SARS-CoV-2 Severe patient subject subset symptom onset symptomatic symptomatic patient T cell T cells T-cell T-cell functionality T-cell Response while [DOI] 10.3389/fimmu.2021.799896 PMC 바로가기 [Article Type] Immunology
Quantitative comparison of SARS-CoV-2 nucleic acid amplification test and antigen testing algorithms: a decision analysis simulation modelSARS-COV-2 핵산 증폭 시험 및 항원 시험 알고리즘의 정량적 비교 : 의사 결정 분석 시뮬레이션 모델Research Published on 2022-01-132022-09-10 Journal: BMC Public Health [Category] SARS, 치료기술, [키워드] addition Algorithm Algorithms amplification Analysis Antigen antigen test antigen tests approach balances COVID-19 Decision analysis detect diagnoses expected False-positive framework Health Organization Health Organizations mathematical model median NAAT nucleic acid nucleic acid amplification nucleic acid amplification tests offer organizations outcome Prevalence Primary outcomes provide Public public health Quantitative reduced reported required resource Result RT-PCR SARS-CoV-2 SARS-CoV-2 nucleic acid SARS-CoV-2 testing seeking sensitivity supplementary material symptom status symptomatic trade-off trade-offs [DOI] 10.1186/s12889-021-12489-8 PMC 바로가기 [Article Type] Research
Rapid antigen testing as a reactive response to surges in nosocomial SARS-CoV-2 outbreak risk병원 내 SARS-CoV-2 발병 위험 급증에 대한 반응성 대응으로 신속한 항원 검사Article Published on 2022-01-112022-09-12 Journal: Nature Communications [Category] 진단, [키워드] addition Ag-RDT Antigen benefit Care Community Computational models Containment measure containment measures COVID-19 diagnostic diagnostic testing Efficacy evaluate Face masks Health hospital incidence Local Long-term care magnitude means nosocomial Nosocomial outbreaks outbreak Population screening Rapid reactive reduced risk RT-PCR testing SARS-CoV-2 SARS-CoV-2 transmission Screening sensitivity social distancing subpopulation subpopulations subsequent symptomatic test type Transmission vaccination viral infection [DOI] 10.1038/s41467-021-27845-w PMC 바로가기 [Article Type] Article
The incidence of COVID-19 infection following emergency use authorization of BBIBP-CORV inactivated vaccine in frontline workers in the United Arab Emirates응급 사용 후 Covid-19 감염의 발생률은 아랍 에미리트의 최전선 근로자에서 BBIBP-CORV 불활성 백신의 승인Article Published on 2022-01-112022-09-10 Journal: Scientific Reports [Category] SARS, 임상, 진단, 치료기술, [키워드] 95% CI BBIBP-CorV clinical trial conducted COVID-19 COVID-19 infection COVID-19 infections dose Emergency use authorization Epidemiology EUA first dose inactivated Inactivated vaccine incidence of COVID-19 incidence rate individual Infection inoculation Medical research Outcomes research PCR positive phase Phase III clinical trials prospective cohort study reported risk SARS CoV second dose Serious Adverse Event Serious Adverse Events seroconversion rate severe disease suffered symptomatic symptomatic infection the vaccine United Arab Emirate vaccinated individual vaccinated individuals vaccination Vaccine [DOI] 10.1038/s41598-021-04244-1 PMC 바로가기 [Article Type] Article
Predominance of antibody-resistant SARS-CoV-2 variants in vaccine breakthrough cases from the San Francisco Bay Area, California Research Published on 2022-01-102022-10-05 Journal: Nature Microbiology [Category] COVID19(2023년), SARS, 변종, 진단, [키워드] analysed analyses Antibody neutralization Area Asymptomatic Breakthrough infection circulating comparable COVID-19 difference Immunocompromised in viral individual individuals infecting Infection infections Lineage Mutation neutralizing antibody remained San Francisco Bay SARS Coronavirus SARS-CoV-2 SARS-CoV-2 variant SARS-CoV-2 variants symptomatic undetectable Vaccine vaccine breakthrough infection vaccine breakthrough infections variant Viral load Whole-genome sequence with COVID-19 [DOI] 10.1038/s41564-021-01041-4 [Article Type] Research
Trajectory of Viral RNA Load Among Persons With Incident SARS-CoV-2 G614 Infection (Wuhan Strain) in Association With COVID-19 Symptom Onset and SeverityCOVID-19 증상 발병 및 중증도와 관련하여 SARS-CoV-2 G614 감염(우한 균주)이 발생한 사람의 바이러스 RNA 부하 궤적Randomized Controlled Trial Published on 2022-01-102022-09-10 Journal: JAMA Network Open [Category] 변종, 임상, 진단, 치료기술, [키워드] association Asymptomatic baseline Characteristics characterized clinical trial Clinical trial design clinical trials Cohort cohort study collected conducted correlated COVID-19 COVID-19 symptom Ct value cycle threshold Cycle threshold value Data analysis enrolled exposure finding Follow-up followed by G614 variant Importance incident individual Infection infections initial laboratory-confirmed SARS-CoV-2 infection linear load measure median median age men Mild symptom mild symptoms mixed-effects model moderate molecular natural history objective occurred Onset pandemic participant peak Person Point positive positive swab prospective cohort study public health referred to Relevance Result RNA SARS-CoV-2 SARS-COV-2 infection SARS-CoV-2 RNA detection SARS-CoV-2 viral SARS-CoV-2 viral load SARS-CoV-2 viral RNA SARS-CoV-2–positive sequenced sample setting severe symptom severity shedding Spread statistical model strain Swab swab sample swab samples Symptom symptom onset symptom severity symptomatic tested the patient the SARS-CoV-2 therapeutic These data trajectory Viral viral lineage Viral load Viral RNA viral shedding viral variant virus were used with COVID-19 women Wuhan Wuhan strain [DOI] 10.1001/jamanetworkopen.2021.42796 PMC 바로가기 [Article Type] Randomized Controlled Trial
SARS-CoV-2 Reinfection Rate and Estimated Effectiveness of the Inactivated Whole Virion Vaccine BBV152 Against Reinfection Among Health Care Workers in New Delhi, IndiaSARS-CoV-2 재감염률 및 비활성화된 전체 Virion 백신 BBV152의 예상 효과Research Published on 2022-01-072022-09-10 Journal: JAMA Network Open [Category] 변종, [키워드] 95% CI adjusted adjusted hazard ratio Against age Analysis association Asymptomatic B.1.617.2 Care categories circulating Cohort cohort study Complete COVID-19 COVID-19 vaccine COVID-19 vaccines Cox proportional hazard Cox proportional hazards model Delta density diagnosed with COVID-19 dose Effectiveness elapsed Estimated event exposure finding follow-up period HCW HCWs Health care Health care worker health care workers HRs Importance inactivated incidence incidence density India infected with SARS-CoV-2 lower risk male measure New objective occurred Partial participant participated Point predominant proportional hazards model Protective Rate reduced risk Reinfection Relevance reported Result retrospective cohort study risk SARS-CoV-2 second dose setting symptomatic symptomatic and asymptomatic the SARS-CoV-2 vaccination vaccination schedule Vaccine variant variant of SARS-CoV-2 virion were infected worker [DOI] 10.1001/jamanetworkopen.2021.42210 PMC 바로가기 [Article Type] Research
Impact of the Coronavirus Disease 2019 (COVID-19) Vaccine on Asymptomatic Infection Among Patients Undergoing Preprocedural COVID-19 Molecular Screening코로나바이러스 질병 2019(COVID-19) 백신이 시술 전 COVID-19 분자 스크리닝을 받는 환자의 무증상 감염에 미치는 영향Article Published on 2022-01-072022-09-12 Journal: Clinical Infectious Diseases: An Official Publicat [Category] SARS, 진단, [키워드] 95% CI acute respiratory syndrome adjusted Adjusted analysis age association Asymptomatic asymptomatic individual asymptomatic infection conducted coronavirus COVID-19 COVID-19 vaccination COVID-19 vaccine demonstrated dose Efficacy Emergency use authorization first dose Healthcare system hospital Impact Infection Local molecular molecular test mRNA mRNA-based vaccine Patient patients performed positive Primary outcome randomized trial reduced risk reduction in regions repeated reported Result retrospective cohort study risk SARS-CoV-2 SARS-COV-2 infection Screening screening test second dose Sex symptomatic Symptomatic patients the United State the vaccine vaccination Vaccine [DOI] 10.1093/cid/ciab229 PMC 바로가기 [Article Type] Article